Bleximenib (J&J-75276617)

AML Global MOA Video 

Contents

Market-Leading Visual Storytellers

  • Build your own system

  • Chapterized scipts

  • Popular packages

  • One-pager

Flexible & Modular Approach for Blexi

  • Narrative development

  • Pricing options

Strategic Services for Blexi

  • Team structure

  • Partnering

Team Structure
& Partnering

  • Bespoke Animation Capabilities

  • Additional capes, work samples, testimonials (Appendix)

Leadership Team

Sean
Rooney, PhD

Chief Medical Strategy

Yury
Stefanov, PhD

Chief Science Officer at MoA, MoD animation Department

Ivan
Konstantinov, MSc

CEO, Founder,
Art Director

Michael
Russo

Strategic Partnerships

17+ years agency experience across multiple disciplines

30+ years life science communications

PhD in Immunology from Harvard University

Jane Coffin Childs Postdoctoral Fellowship at Rockefeller University

Former Managing Partner within HCG (an Omnicom company) and Chief Science Officer at VML Health (a WPP company)

Dean of OncU (Omnicom)
and faculty at Oncology Academy (WPP)

Health tech startups, global agency networks

Onc/hem global launches, IMIDs, PD-1, etc.

Software & technology
solutions for Pharma

B.S. Marketing & Advertising Emerson College

Omnicom executive leadership program: Harvard led

15+ years life science communications across
multiple disciplines

PhD molecular biology

300+ animation developed
for TOP pharma companies

49 awards received, including  two from Science and National Science Foundation

16+ years life science communications across
multiple disciplines

20+ years digital communications

MSc molecular biology

Professional Biomedical Illustrator (AMI)

49 awards received, including  two from Science and National Science Foundation

We support Biotechs and Pharma
at every stage of the life cycle

PRECLINICAL

DEVELOPMENT

CLINICAL DEVELOPMENT

Phase 1  |  Phase 2  |  Phase 3

LAUNCH /
POST LAUNCH

 

BRAND MATURITY
Phase 4

 

 

Trusted by Top-20 Pharma and 100+ small and medium Biotechs

High Science. Tech-Enabled

Strategy

Content

Digital + Social

Most Tech-enabled

We are pioneering innovative solutions fueled by proprietary
technologies, top tech, science and creative talent

  • MoD/MoA animation
    and illustration

  • Corporate & IR decks

  • Field content

  • Congress booth programs

  • Websites

  • 75% of routine steps are automated using proprietary software and machine learning.

  • The most efficient production pipeline with 3x faster delivery.

  • Data-driven feedback loop optimization for every asset.

 

  • Live strategy workshops

  • Scientific communications
    platform (ScP), lexicon

  • Content optimization
    and channel planning

  • Microcontent planning
    and development:

  • Custom apps

  • Veeva-trained staff

  • Animated data

  • 15-second videos

  • Visual digests

All fueled by the most advanced production pipeline in the industry

15 years in hematology & oncology space 

50+

Collaboration with EHA

  • Clonal hematopoiesis (CHIP): mechanisms and consequences

  • The leukemic Bone Marrow niche and pathogenesis of AML

  • BCL2: genetic alteration and role in lymphoid malignancies

  • Mechanisms of action: CAR-T cells

  • Mechanisms of action: Bispecific Abs

  • Mechanisms of action: small molecules inhibitors

  • The role of epigenetic mechanisms in hematological malignancies

  • Techniques: NGS (TIF: PH)

  • Techniques: qPCR (TIF: PH)

  • Techniques: single cell genetics (TIF: pH)

  • Von Willebrand factor structure and defects

  • AI in hematology: AI-based digital morph. analysis

  • Synthetic patients in clinical trials

  • RBCs: Hb linking and releasing O2

Selected Animations:

Collaboration with Scientific Publishers, Foundations and Patient organizations

10 Universities:

5 Publishers:

15+ Patient Organizations
and Foundations

Market-Leading
Visual Storytellers

6 animation types 

and 20 subtypes for every need — audience, company stage and budget.

INCLUDING TWO UNIQUE

High-End 3D
 

The most advanced animation type on the market, based on computational biology methods. Science-grade molecular simulations for unprecedented accuracy.

Read more about the methods we use for this animation type in the whitepaper.

 

 

UNIQUE SCIENTIFIC-GRADE TYPE

High-End 3D
Coronavirus atomic resolution model

Featured:

Read more about the methods we use for this animation type in the whitepaper.

 

 

UNIQUE SCIENTIFIC-GRADE TYPE

High-end 3D
HIV Atomic Resolution Model

Featured:

Awarded:

UNIQUE SCIENTIFIC-GRADE TYPE

Main 3D

Main 3D is the most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic. It's a great match for most MoAs and MoDs for IR needs, alongside HCP communications.

Main 3D + 2D

 

The usual Main 3D animation type in combination with 2D elements. This is an excellent option for MoAs where there's a need to incorporate research data, schematics, or other additional information.

UNIQUE APPROACH

2D Animation

For Nature Journal

A relatively simple, yet still eye-catching 2D animation style is an ideal option for explainer animations, platform or AI-based technologies, alongside cases where IP details must not be disclosed.

2D Animation:

For HCP and Patient Education
 

Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos

Character Animation:

For HCP and Patient Education
 

Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos

Deck3D
 

This type is designed specifically for projects with tight deadlines. Through optimization, we achieve a rapid turnaround without compromising quality or scientific accuracy. The fastest type of 3D animation to produce on the market. 

UNIQUE

Pathway3D

Scientific-grade models with the fastest turnaround — delivered in days, not months

A unique combination of scientific-grade molecular simulations that accurately represents real molecular interactions and states, with all the benefits of 2D animation —affordable and fast to produce. Unbeatable quality-to-cost-per-second ratio.  

UNIQUE

Clinical trial update videos

Top 20 Pharma undisclosed client, anonymized data

Animation type:
Clinical trial update

Time:

1 week

 

Client:

Undisclosed

 

 

 

Education & Impact: 500M+ views

and 100+ more

The Most Tech Enabled

75% of Tasks Automated via Algorithms, Machine Learning, and AI Agents

3D type

High-end 3D

Deck3D

2D type

Pathway3D

+20 subtypes

7-8 weeks

8-10 weeks

4-5 weeks

3-5 weeks

10 days

1-9 weeks

In-House
Studio

STRATEGY

DISCOVERY

Delivering Accuracy & Efficiency for Blexi

Production Approach

Layered Animation

Animation Mix

Modular Asset Design

We are pioneering innovative solutions fueled by proprietary
technologies, top tech, science and creative talent

 We adopt a layered approach for our video animations, adding a customizable 2D layer atop the main 3D or high-end 3D visuals. This method allows for rapid repurposing of content for any event or audience, often with negligible additional costs.

 

A modular structure for our assets facilitates easy repurposing for different media and audiences with minimal effort. This flexibility significantly enhances each asset’s value and lifespan.

 

By streamlining our processes through hundreds of projects and automating outdated practices with proprietary software, we not only achieve superior quality at competitive prices, but also deliver projects up to three times faster.

We carefully select from our range of six main animation types and twenty subtypes to ensure we use the most effective and cost-efficient animation for each scene. Typically, a project might incorporate two to four different animation styles.

All fueled by the most advanced production pipeline in the industry

Flexible & Modular Approach for Blexi

Confidential — Not for Public Consumption or Distribution

Flexible and Modular Approach for Blexi

OPTIONS COMPLEXITY LENGTH 
Option A
 
High-end type
The most advanced animation type on the market, based on computational biology methods. Science-grade molecular simulations for unprecedented accuracy.
~ 3.5 min
Option B
 
Main3D + 2D types
The most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic combined with a relatively simple, yet still eye-catching 2D animation style
~ 3.5 min
Option C
 
Main3D, Deck3D, 2D types
Combines the most universal, eye-catching 2D, and Deck3D eye-catching like our main 3D, but slightly less detailed backgrounds
~ 3.5 min
Option D
 
Main3D + 2D shortened version
The most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic combined with a relatively simple, yet still eye-catching 2D animation style
~ 2.5 min

The "build your own" system provides complete transparency and flexibility in the planning phase, allowing tailoring to specific needs, audience, and budget.

 

Initial "chapterized" scripts and pricing for Blexi MOA provided under separate cover based on preliminary options below. Additional animation styles/options can be tailored further with additional discovery.

Short formats & Chapterized assets for Blexi 

 

UNIQUE

Popular packages for 60-90 second MoA

BuildYourOwn — A Unique Pricing System

Entry Package

Solid Base

One of a Kind

Very Best of 3D

$30-45K/minute

or

$50-60K/minute

$65-80K/minute

$120-200K/minute

100%

Pathway 3D

Most Chosen by Clients

100%

2D or Patient 2D

60%

Deck 3D

40%

Main 3D

60%

Main 3D

30%

Main 3D + 2D

10%

High-end 3D

90%

High-end 3D

10%

Main 3D

* Initial "chapterized" scripts and pricing options for Blexi MOA provided under separate cover and can be tailored further.

Blexi one-pager infographic leave behind

Development of 1 infographic leave behind for multichannel use:

 

Hours and OOPs assume Visual Science to:

  • Development of a front back leave behind for multichannel use

  • Utilize existing JNJ Medical look/feel to develop layout

  • Content and imagery leveraged from video animation

    • Introduction to AML

    • Mutations in develpment of AML

    • KMT2A in AML

    • NMP1 in AML

    • Mennin as a druggable target in AML

    • Menin inhibitors and advantages of Bleximenib

  • Includes full editorial QC (copyedit, annotation and fact check) prior to each Med/Legal review

  • Client reviews assume 3 rounds of client revisions (1 round for outline review, 1 prior to submission of layout for MLR review, 1 round prior to final MLR approval). Visual Science to prepare for 2 rounds of Med/Legal submission; 1 for review for revisions; BGB to upload into Veeva for final approval

  • OOP Assumptions assume art usage rights, artist illustration, and retouching.

Price range: $25-$30k

Confidential — Not for Public Consumption or Distribution

Relevant Work Sample

Front 

Back

Strategic Services for Blexi

SCIENTIFIC NARRATIVES, PLATFORMS,  LEXICON DEVELOPMENT

  • A medical strategic team that has developed
    100+ narratives and scientific platforms

  • Expertise spanning early pipeline programs
    to blockbuster therapies

Much More Than a "Scientific Platform"

01

A cross-functional strategic exercise
to define the clinical value and scientific
rationale of your molecule

02

A clear and compelling story
scalable for all external audiences

03

An internal asset that expedites
approval of external facing assets
 

Confidential — Not for Public Consumption or Distribution

SCIENTIFIC
PLATFORM

Medical Affairs

Commercial

Regulatory

Clinical Program

IR & Corporate Comm.

Payer/Market Access/HEOR

Scalable from Early to Late-Stage Programs

The overarching story
of your molecule and
the clinical challenge
it solves

NARRATIVE

Breaks down the narrative into 5-6 discrete topics,
such as unmet need,
MOA, and clinical
trial results

CONCEPTS

5-8 evidence driven Statements which
support each
Concept

STATEMENTS

Hyperlinked and annotated reference
that support each statement

EVIDENCE

Identifiable Evidence
Gaps Needed to Tell
Full Story of your product

GAPS

Program development:

 

Confidential — Not for Public Consumption or Distribution

The Visual Science Process

The VS medical team will review available evidence, and  generate
the brief that summarizes

the project plan.

DEFINE THE STRATEGY

VALIDATE & ROLLOUT

VALIDATE & ROLLOUT

ANALYZE THE

LANDSCAPE

Download
Meeting

Mindset
workshop

Draft Core
Concepts

Draft Scientific Statements

Curate Scientific Evidence

Expert
Validation

Functional
Roll-out

Our team and
your internal stakeholders will workshop current audience mindsets, and ID changes
that can ease product uptake.

Informed by the mindset workshop,
VS will draft
an overarching scientific narrative and core concepts to be reviewed by the core team.

With the core concepts settled,
we draft scientific statements to support each
core concepts
and review with
the core team.

The VS team will align & annotate evidence to
agreed scientific statements.

Once evidence is finalized, it is key
to validate with
your audience.

Once finalized,
we recommend reengaging the extended team
to review and adopt.

01

The core team will align with
Visual Science and drive the effort kickoff to delivery.  

02

The Visual Science team will moderate this process taking in and adjudicating perspectives.

03

Extended team includes stakeholders from all internal functions, to take
in perspectives from multiple lenses.

KOLs for veracity, community to test resonance.

Confidential — Not for Public Consumption or Distribution

Expert Insights
Deliverable
Slide set in PPT including results from audit,
high-level narrative and key data gaps

(up to 40 slides)

Scientific Platform Pricing

Workshops
Evidence
Early clinical data, Data on file (DOF),
competitive data
Current asset data, competitive
data included as bibilography
Current asset data, competitive data, fully
annoted/referenced, and key evidence gaps
Scientific Debrief only
Virtual workshop up to 2 hours and summary of key
findings in PPT (8-10 slides)
1/2 Day workshop with up to 5-7 key
company stakeholders; Summary of key
decisions in PPT (15-20 slides)
Incorporate secondary market research
and/or expert feedback captured via AdBds
or Investigators Meetings
Conduct 1-2 one-hour Expert Interviews
and incorporate feedback
Workshop with 3-5 Experts;
remote meeting up to 2 hours
Slide set in PPT including results from audit,
high-level narrative and key data gaps

(up to 15 slides)
Online Scientific Platform with access
for multiple stakeholders
Narrative/Platform
and Lexicon
Generate high-level narrative focused on unmet
needs in disease state, key differentiating features
of the asset
Narrative and Platform initiation, including
level 1 core concepts; Level 2 Scientific statements;
placeholders for key evidence needed
Full Scientific Platform including Narrative Level 1,
Scientific Statements Level 2, and Key pieces
of evidence Level 3
Asset 1
Landscape assessment, review of pre-clinical
or early stage data, competitive assesment
Landscape assessment, competitive assessment,
market research, Add summaries,
and medical download call
Landscape assessment, competitive assessment,
market research, AdBd summaries, and medical
download call; 5-7 slide summary of audit

Early Stage (Clin-P1)

Mid Stage (P1-P2)

Late Stage (P2-Pre-Launch)

PACKAGE 2
PACKAGE 3
PACKAGE 1
Timing
kickoff to delivery
8-10 weeks
4-6 Weeks
12-15 weeks
Ballpark
fees only
$80-100K
$45-65K
$120-150K

 

Partnering

Your Visual Science Team*

MEDICAL WRITING / STRATEGY

MEDICAL

ACCOUNT

PROJECT MGMT

CREATIVE & TECH

Sean Rooney, PhD

Chief Medical Strategy

Chief Executive Officer

Michael Russo

Head, Strategic Partnerships

Ivan K., M.Sc

Jenn Terrell, MBA

Client Services Lead

Yury Stefanov, PhD

Nancy Miller

Marianna Jain

Associate Director,
Project Management

Lori Magnelli

VP, Managomant
Supervisor

Marni Kelman. M.Sc

Rich Friel

Lori Magnelli

Associate Project
Manager

Nicole Cooper

Dan Purkis

Qais Saket

Medical Writer
Medical Writer
Medical Writer
Medical Writer
Chief Science Offer
Medical Doctor
Associate Medical
Director

Max Kulemza

Head of CG & Tech

Tobias Van Schnider

VP, IT

* All employess are full time

EXECUTIVE MANAGEMENT

Additional support resources (Editorial, Studio, Digital, Production, Presentation Services) are available to meet your needs

Alex Whitewood

VP, Creative Director

Ihor Cherno

VP, VFX

Nicole Cooper

Associate Medical
Director

Appendix

DECKS AND INFOGRAPHICS

 

97% of clients rate working with us 9 or 10/10

Atsena Tx. Investor deck

 

Type:
Series B deck

 

Time:

6 weeks

 

Scope:

IR, scientific flow optimization, design, illustrations, animations
 

 

 

 

Jasper Tx (NASDAQ: JSPR) – Corporate Deck

 

Type:
Corporate deck  for public company

 

Time:

4 weeks

 

Scope:

Design, illustrations, animations
 

 

 

 

Hookipa (NAS: HOOK) – Corporate Deck

 

Type:
Corporate deck  for public company

 

Time:

5 weeks

 

Scope:

Scientific flow optimization, design, illustrations, animations
 

 

 

 

3D Infographics and Illustrations

Type:
High-end 3D infographics for deck

 

Time:

1 week

 

 

 

 

 

 

2D Infographics and Illustrations

Type:
2D infographics for deck

 

Time:

1 week

 

 

 

 

 

 

MoA Illustrations for Decks

WEB & APPS

 

97% of clients rate working with us 9 or 10/10

APOGEE Tx: Web-site / MoA / Deck

NASDAQ: APGE

Type:
Corporate website for public company

 

Time:

10 weeks

 

Scope:

Design, development, illustrations, animations
 

 

 

 

Enveric Biosciences Web-site

NASDAQ: ENVB

Type:
Corporate website for public company

 

Time:

9 weeks

 

Scope:

Design, development, illustrations, animations
 

 

 

 

Touch Panels and Interactive Decks

For congress support and in field communications

Plain Language Summaries — Now in Visual Form

 

UNIQUE

POSTER AR 

 

97% of clients rate working with us 9 or 10/10

PosterAR platform

 

UNIQUE

PosterAR platform

 

UNIQUE TECHNOLOGY

Mobile-first version of the poster

PPT slides with key takeaways

Client Testimonials


97% of clients rate working with us 9 or 10/10

High-end 3D + Pathway 3D

12 days — yes, days!

10 weeks

High-end 3D

High-end 3D

12 weeks

2D

8 weeks

High-end 3D

10 weeks

High-end 3D

10 weeks

3D

7 weeks

Main 3D

8 weeks

High-end 3D

8 weeks

High-end 3D

High-end 3D

9 weeks

3D

4 weeks

Simplified 3D

Have we piqued your interest? Let's chat.

JNJ Visual Science | June 18 25

By Visual Science

JNJ Visual Science | June 18 25

Visual Science is an award-winning biomedical visualization and animation company which brings scientists, software engineers, designers and computer graphics specialists under one roof to produce visual content and graphics that are eye-catching and scientifically rigorous. Since 2007, we’ve helped both Fortune 500 and small companies around the world share cutting-edge ideas using clear, compelling graphics. Our graphics have been featured by leading media outlets and viewed hundreds of millions of times.

  • 111